论文部分内容阅读
蚓激酶胶囊是中国科学院生物物理研究所自主研制的国家级二类新药。于1992年4月获卫生部颁发的新药证书并进行试生产,1995年1月批准为正式生产。 蚓激酶及其胶囊是以传统中医药学为依据,从蚯蚓(地龙)中分离纯化得到的水解蛋白酶制剂。1千多年前,《本草纲目》中就记载了地龙是主治肢体麻木、半身不遂、清热定惊、活血化瘀的药物。
The lumbrokinase capsule is a national class II new drug independently developed by the Institute of Biophysics of the Chinese Academy of Sciences. In April 1992, the Ministry of Health issued a new drug certificate and trial production. In January 1995, it was approved as a formal production. Lumbrokinase and its capsules are hydrolyzed protease preparations isolated and purified from the earthworm (Dragonidae) based on traditional Chinese medicine. More than 1,000 years ago, in the “Compendium of Materia Medica,” it was recorded that earthworms are drugs that treat numbness in the limbs, hemiplegia, heat-shock, and blood circulation.